GLP-1 Weight Loss Treatment Eligibility Criteria

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Glucagon-like peptide-1 (GLP-1) receptor agonists have transformed weight management for millions of people who struggle with traditional dieting alone. Clinical trials show that patients using GLP-1 therapy lose 15-22% of body weight over 68 weeks, making these medications among the most effective weight loss tools available today. Understanding who qualifies for GLP-1 treatment is the first step toward achieving your health goals with PlexusDx.

Basic Medical Requirements for GLP-1 Eligibility

PlexusDx evaluates each patient through a medical history review and consultation process rather than a single rigid criterion. Most candidates have a body mass index (BMI) of 27 or higher, especially if they also have weight-related conditions like type 2 diabetes, high blood pressure, or heart disease. Your PlexusDx healthcare provider will assess your current medications, past medical events, and lifestyle to determine if GLP-1 therapy fits your individual health profile.

Age requirements vary, but PlexusDx typically works with adults aged 18 and older. Patients must have no contraindications to GLP-1 medications, including a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. A straightforward medical questionnaire helps PlexusDx identify any conditions that might affect your safety or suitability for treatment.

Weight and BMI Thresholds for GLP-1 Candidacy

While a BMI of 30 or higher has traditionally defined obesity, many patients with a BMI between 27-29.9 qualify if they have related health conditions. PlexusDx recognizes that weight-related complications—such as prediabetes, joint stress, or metabolic syndrome—often appear at lower BMI levels in certain individuals. Your exact threshold depends on your health history, not just a number on a scale.

Absolute weight is less important than the impact of your current weight on your health and quality of life. If you experience shortness of breath, joint pain, sleep disruption, or metabolic markers that concern your doctor, you may qualify regardless of whether your BMI falls in a textbook range. PlexusDx evaluates the whole picture: your symptoms, your goals, and your medical timeline.

Mental Health and Lifestyle Readiness for GLP-1 Treatment

Successful GLP-1 therapy requires realistic expectations and commitment to ongoing lifestyle changes. PlexusDx screens for active substance abuse disorders or untreated psychiatric conditions that could interfere with treatment adherence or health outcomes. Patients who view GLP-1 as a tool alongside nutrition, movement, and sleep—rather than a standalone fix—experience the best results.

Your PlexusDx provider will discuss your motivation level, previous weight loss attempts, and barriers you've faced. If you're curious about whether you fall into a specific health pattern, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after first month), which maps 14 pathways and 49 peptides to reveal your unique appetite regulation and metabolism tendencies. This personalized data can clarify whether GLP-1 is the right fit for your genetic predisposition.

Medication History and Drug Interaction Screening

PlexusDx reviews all current medications during your consultation because GLP-1 drugs can interact with certain treatments, especially insulin and diabetes medications. If you take medications for blood pressure, thyroid disease, or psychiatric conditions, your PlexusDx provider will assess compatibility and adjust your regimen if needed. Transparency about over-the-counter supplements and herbal products is equally important.

Patients with a history of pancreatitis, gallbladder disease, or severe kidney disease require careful evaluation before starting GLP-1 therapy. PlexusDx may order basic blood work or refer you to a specialist if your medical complexity warrants it. The goal is to ensure your safety while maximizing the benefits of Semaglutide Injection (starting at $149/mo) or another GLP-1 option that suits your needs.

Access and Affordability: No Insurance Required

Unlike traditional weight loss programs, PlexusDx does not require health insurance enrollment. PlexusDx serves all 50 states with flat monthly pricing that does not change as your dose increases—a model designed to remove barriers for uninsured and underinsured patients. Your dose may need to go up. Your price won't.

PlexusDx accepts HSA and FSA funds, making GLP-1 therapy eligible for tax-advantaged health spending. Patients who qualify financially may also explore patient assistance programs. The absence of membership fees, insurance denials, or prior authorization delays means you can begin treatment quickly once PlexusDx confirms your candidacy through a simple online assessment.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I need a specific BMI to qualify for PlexusDx GLP-1 treatment?

PlexusDx evaluates candidates holistically rather than applying a single BMI cutoff. Most patients have a BMI of 27 or higher, especially if they also have weight-related health conditions. Your PlexusDx provider will review your complete health profile to determine eligibility.

Can I use GLP-1 therapy if I'm already on diabetes medication?

Yes, but PlexusDx requires a medication review because GLP-1 drugs can interact with insulin and some diabetes pills. Your provider will coordinate with your other care team members to adjust doses safely if needed.

What if I have a history of thyroid cancer or pancreatitis?

PlexusDx considers these conditions carefully because GLP-1 medications carry specific cautions for patients with a personal or family history of medullary thyroid carcinoma or severe pancreatic disease. Your provider may refer you to a specialist for clearance before treatment begins.

How much does GLP-1 treatment cost at PlexusDx, and do I need insurance?

PlexusDx offers Semaglutide Injection starting at $149/mo with no insurance requirement. Pricing remains flat regardless of dose increases, and PlexusDx accepts HSA/FSA funds. No membership fees or prior authorization delays apply.

Can the Precision Peptide Genetic Test help me decide if GLP-1 is right for me?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 pathways and 49 peptides to reveal how your body regulates appetite and metabolism. This data helps you understand your unique predisposition and whether GLP-1 therapy aligns with your genetic profile.

What if I'm underweight or have a normal BMI but want to try GLP-1?

PlexusDx generally does not prescribe GLP-1 medications for patients without weight-related health concerns or a higher BMI. GLP-1 therapy is designed as a medical intervention for weight management or metabolic disease, not cosmetic weight loss in healthy individuals.

Who Qualifies for a GLP-1 Weight Loss Treatment?